(E)-4-(3-(3-(4-fluorophenyl)acryloyl)-2-oxoimidazolidine-1-carbonyl)benzonitrile

ID: ALA4745627

PubChem CID: 162648175

Max Phase: Preclinical

Molecular Formula: C20H14FN3O3

Molecular Weight: 363.35

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  N#Cc1ccc(C(=O)N2CCN(C(=O)/C=C/c3ccc(F)cc3)C2=O)cc1

Standard InChI:  InChI=1S/C20H14FN3O3/c21-17-8-3-14(4-9-17)5-10-18(25)23-11-12-24(20(23)27)19(26)16-6-1-15(13-22)2-7-16/h1-10H,11-12H2/b10-5+

Standard InChI Key:  MGFBFBHGEUZTBV-BJMVGYQFSA-N

Molfile:  

 
     RDKit          2D

 27 29  0  0  0  0  0  0  0  0999 V2000
   28.4839  -26.2381    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.5823  -25.4047    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.5812  -26.2320    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.2960  -26.6449    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.0125  -26.2315    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.0096  -25.4010    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.2942  -24.9918    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.7225  -24.9858    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.4386  -25.3956    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.1515  -24.9804    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.8675  -25.3902    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   25.1484  -24.1554    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   25.9592  -26.2097    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.7669  -26.3782    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.1767  -25.6621    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   26.6223  -25.0512    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.7909  -24.2436    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   27.9968  -25.5728    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.3295  -24.8178    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   20.8664  -26.6439    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   28.1483  -26.9923    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.6346  -27.6572    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.4552  -27.5684    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.7871  -26.8090    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.2988  -26.1473    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.9460  -28.2301    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.4342  -28.8951    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  2  1  0
  6  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  1  0
 10 12  2  0
 11 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 11  1  0
 16 17  2  0
 15 18  1  0
 18  1  1  0
 18 19  2  0
  3 20  1  0
  1 21  2  0
 21 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  2  0
 25  1  1  0
 26 27  3  0
 23 26  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4745627

    ---

Associated Targets(non-human)

PC-12 (7051 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 363.35Molecular Weight (Monoisotopic): 363.1019AlogP: 2.82#Rotatable Bonds: 3
Polar Surface Area: 81.48Molecular Species: NEUTRALHBA: 4HBD:
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: CX LogP: 3.10CX LogD: 3.10
Aromatic Rings: 2Heavy Atoms: 27QED Weighted: 0.79Np Likeness Score: -1.15

References

1. Ji L,Qu L,Wang C,Peng W,Li S,Yang H,Luo H,Yin F,Lu D,Liu X,Kong L,Wang X.  (2021)  Identification and optimization of piperlongumine analogues as potential antioxidant and anti-inflammatory agents via activation of Nrf2.,  210  [PMID:33148493] [10.1016/j.ejmech.2020.112965]

Source